Cargando…
Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia
The intrinsic humoral immunodeficiency of chronic lymphocytic leukemia (CLL) is often managed with immunoglobulin replacement therapy (IgRT) to maintain IgG levels in the low-normal range (6–8 g/L) but optimal targets for IgG and timing to commence IgRT are unclear. IgG levels fell near 6 g/L at rat...
Autores principales: | Spaner, David E., Venema, Robertson, Huang, Justin, Norris, Peter, Lazarus, Alan, Wang, Guizhi, Shi, Yonghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156707/ https://www.ncbi.nlm.nih.gov/pubmed/30174282 http://dx.doi.org/10.1016/j.ebiom.2018.08.045 |
Ejemplares similares
-
Low Density Lipoproteins Amplify Cytokine-signaling in Chronic Lymphocytic Leukemia Cells
por: McCaw, Lindsay, et al.
Publicado: (2016) -
Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo
por: Spaner, David E., et al.
Publicado: (2023) -
Lymphocyte membrane IgG and secreted IgG are structurally and allotypically distinct
Publicado: (1980) -
Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022) -
The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia
por: Naseraldeen, Naseba, et al.
Publicado: (2021)